Randomised clinical trial: tegoprazan, a novel potassium-competitive acid blocker, or lansoprazole in the treatment of gastric ulcer.

Yu Kyung ChoMyung-Gyu ChoiSuck Chei ChoiKee Myung LeeTae Oh KimSoo-Heon ParkJeong Seop MoonYun Jeong LimDae Hwan KangGab Jin CheonGwang Ho BaikKyoung Oh KimKwang Bum ChoJin Seok JangJong-Jae ParkByoung Kwan SonHye Kyung Jung Byung-Wook KimSung Kuk KimSoo Teik LeeJae Myung ChaAh Rong KimEun Ji KimHyun Wook ParkGeun Seog Song

Published in: Alimentary pharmacology & therapeutics (2020)

Tegoprazan 50 or 100 mg were not inferior to lansoprazole 30 mg once daily in the treatment of gastric ulcers.

Keyphrases

clinical trial
open label
study protocol
randomized controlled trial
physical activity
angiotensin ii
replacement therapy